Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
Germany
/
Materials
/
AlzChem Group
ACT
AlzChem Group
Mounting Regulatory And Raw Material Headwinds Will Undermine Specialty Chemicals
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 5 Analysts
Published
25 Jul 25
Updated
25 Jul 25
0
Set Fair Value
0
votes
Share
AnalystLowTarget
's Fair Value
€97.00
59.2% overvalued
intrinsic discount
25 Jul
€154.40
Loading
1Y
203.9%
7D
14.2%
Author's Valuation
€97.0
59.2% overvalued
intrinsic discount
AnalystLowTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystLowTarget Fair Value
€97.0
59.2% overvalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
0
711m
2014
2017
2020
2023
2025
2026
2028
Revenue €711.3m
Earnings €78.0m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
8.70%
Chemicals revenue growth rate
0.47%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
5.20%
Calculation
€78.04m
Earnings '28
x
14.46x
PE Ratio '28
=
€1.13b
Market Cap '28
€1.13b
Market Cap '28
/
10.18m
No. shares '28
=
€110.91
Share Price '28
€110.91
Share Price '28
Discounted to 2025 @ 5.18% p.a.
=
€95.32
Fair Value '25
